Farmaceutica R
Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company provides packaging materials; and logistics, promotion and marketing of drugs, and pharmaceutical products registration services. The company was incorporated in 1991 and is headqua… Read more
Farmaceutica R (RMAH) - Total Liabilities
Latest total liabilities as of September 2025: RON291.45 Million RON
Based on the latest financial reports, Farmaceutica R (RMAH) has total liabilities worth RON291.45 Million RON as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Farmaceutica R - Total Liabilities Trend (2020–2024)
This chart illustrates how Farmaceutica R's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Farmaceutica R Competitors by Total Liabilities
The table below lists competitors of Farmaceutica R ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
APPLIED MATERIALS
MU:AP2
|
Germany | €14.81 Billion |
|
Taiwan Green Environment Technology Inc.
TWO:5205
|
Taiwan | NT$39.07 Million |
|
City Steel Public Company Limited
BK:CITY
|
Thailand | ฿21.36 Million |
|
Altshuler Shaham Financial LTD
TA:ALTF
|
Israel | ILA906.21 Million |
|
Ahlada Engineers Limited
NSE:AHLADA
|
India | ₹785.46 Million |
|
Stradim Espace Finances SA
PA:ALSAS
|
France | €190.89 Million |
|
Gafisa S.A
SA:GFSA3
|
Brazil | R$2.99 Billion |
|
Trinitan Metals and Minerals
JK:PURE
|
Indonesia | Rp867.76 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Farmaceutica R's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Farmaceutica R's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Farmaceutica R (2020–2024)
The table below shows the annual total liabilities of Farmaceutica R from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-09-30 | RON301.09 Million | +22.94% |
| 2023-09-30 | RON244.90 Million | +12.46% |
| 2022-09-30 | RON217.77 Million | +19.10% |
| 2021-09-30 | RON182.85 Million | +11.07% |
| 2020-09-30 | RON164.63 Million | -- |